Filter
2538
Filtered Results: 2538
Text search:
antibióticos
Featured
Recommendations
295
New Publications
672
Language
Document type
No document type
1205
Guidelines
444
Studies & Reports
382
Manuals
135
Fact sheets
114
Strategic & Response Plan
84
Training Material
63
Infographics
24
Situation Updates
22
Videos
19
Online Courses
17
Resource Platforms
15
Brochures
13
Dashboards/Maps
1
Countries / Regions
India
178
Kenya
72
South Africa
70
Ethiopia
64
Nepal
62
Global
61
Uganda
45
Nigeria
44
Sierra Leone
42
Bangladesh
40
Africa
35
Malawi
33
Western and Central Europe
33
Ghana
30
Tanzania
29
Rwanda
27
Liberia
27
Philippines
24
Namibia
23
Myanmar / Burma
22
Haiti
21
Latin America and the Carribbean
20
Zambia
18
Madagascar
17
Zimbabwe
16
Syria
15
Mozambique
13
Cambodia
11
Venezuela
11
Indonesia
11
Burkina Faso
10
Germany
10
South–East Asia Region
10
Lesotho
9
Paraguay
9
Eastern Europe
9
Brazil
9
Ukraine
8
Cameroon
8
Congo, Democratic Republic of
8
Botswana
8
Eswatini/ Swaziland
8
Senegal
7
East and Southern Africa
7
Russia
7
West and Central Africa
6
Eastern Europe and Central Asia
6
Argentina
6
Tajikistan
5
Thailand
5
Middle East and North Africa
5
Vietnam
5
South Sudan
5
Somalia
5
Colombia
4
El Salvador
4
USA
4
Western Pacific Region
4
Sudan
4
Mali
4
North Macedonia
3
China
3
Laos
3
Peru
3
Guinea
3
Asia
3
Bolivia
3
Papua New Guinea
3
Yemen
3
Iraq
3
Pakistan
3
Serbia
2
Benin
2
Fiji
2
Afghanistan
2
Guinea-Bissau
2
Jordan
2
Uruguay
2
France
2
United Kingdom
2
Spain
2
Angola
2
Ecuador
2
Switzerland
1
Mexico
1
Australia
1
Gambia
1
Kazakhstan
1
Chile
1
Iran
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Malaysia
1
Morocco
1
Qatar
1
Armenia
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Egypt
1
Georgia
1
Central African Republic
1
Honduras
1
Libya
1
Bhutan
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
949
Clinical Guidelines
316
Women & Child Health
193
Key Resources
106
Public Health
96
Capacity Building
59
Pharmacy & Technologies
30
Annual Report MEDBOX
1
Toolboxes
AMR
476
TB
139
NTDs
118
COVID-19
115
Rapid Response
113
Pharmacy
106
Caregiver
102
HIV
65
Planetary Health
65
Cholera
61
Ebola & Marburg
52
Refugee
42
Conflict
39
Mental Health
36
Global Health Education
32
NCDs
26
Natural Hazards
21
Specific Hazards
15
Disability
14
Polio
13
Health Financing Toolbox
3
Social Ethics
2
Zika
1
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces o...
Policy Brief November 2021 Available in English, Spanish and Portuguese
The COVID-19 pandemic has fueled the ongoing antimicrobial resistance (AMR) global crisis due to the increase in the use of antibiotics to treat COVID-19 patients, disruptions to infection prevention and control practices in o...
23 April 2020EMA/202483/2020 Rev
Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated if treatment is combined with other medicines, such as the antibiotic azithromycin, that have similar effects on the heart.
The NICE guideline NG114 provides recommendations on antimicrobial therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD), aiming to optimize antibiotic use and minimize the development of antibiotic resistance.
La quincuagésima primera Asamblea de la Salud Mundial aprobó la resolución WHA51.11 en
1998, que busca la eliminación mundial del tracoma como problema de salud pública para el 2020
(1). La estrategia recomendada para lograr ese objetivo está encapsulada por las siglas "SAFE", que
represent...
La publicación que aquí presentamos busca mostrar los resultados de la iniciativa SAIDI en los países intervenidos, para ello se entrega un perfil que muestra el panorama de la situación de la resistencia antimicrobiana, pre y post iniciativa, así como información clave de los actores que trab...
En los últimos decenios, el estado general de salud de las personas ha mejorado considerablemente, lo que ha llevado a un aumento de la esperanza de vida al nacer en la mayor parte de los países de la Región de las Américas. Este progreso ha sido el resultado tanto de los avances en las tecnolog...
Cotonou declaration on buruli ulcer
recommended
Cotonou Declaration oBuruli Ulcer
Cotonou, Benin, 30 March 2009
Neglected tropical diseases kill, weaken or incapacitate millions of people every year, causing permanent physical suffering, social stigmatization and reduced productive capacity. Buruli ulcer, one such disease, causes immense suffer...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
An essential participant in antimicrobial stewardship who has been unrecognized and underutilized is the“staff nurse.”Although the role of staff nurses has not formally been recognized in guidelines for implementing and operating antimicrobial stewardship programs (ASPs) or defined in the medica...
Antimicrobial resistance (AMR) is impacting our health, economies and development. Up to 5.2 million people may die because of resistant bacterial infections across the Western Pacific Region from 2020-2030. Childbirth, surgery, cancer treatment and other interventions will become impossibly d...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Clinical Presentation and Management for Haiti Cholera Outbreak, 2010
The document provides detailed guidelines for diagnosing and managing cholera cases, with a focus on rehydration therapy and preventing dehydration-related fatalities. It outlines the use of oral rehydration salts (ORS), intrav...
The video "Cholera - Questions & Answers" by the World Health Organization (WHO) explains the essential aspects of cholera, an acute diarrheal disease caused by ingesting water or food contaminated with the Vibrio cholerae bacterium. It highlights the main symptoms, including severe watery diarrhea,...
Issue Brief 31: Antimicrobial resistance (AMR) can occur when viruses, bacteria, parasites and fungi change over time. There is no longer a response to medicines, and the infection treatment gets really difficult which increases the risk of a disesase spread, which can lead to severe health problems...
The authors conduct an integrated survey of Antimicrobial Resistant Organisms (AMR) in drinking water, wastewater and surface water in three settings in Bangladesh: rural households, rural poultry farms, and urban food markets. Results show that untreated water discharged from rural households, poul...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
